Clinical Trial Update: Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year. [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing safety and immunogenicity of the RSV-F vaccine in older adults previously treated with the same vaccine or placebo in the prior year.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV F vaccine (RSV F protein vaccine)

Snippet

Sponsor: Novavax | Conditions: Respiratory Syncytial Virus (RSV) | Phase 2 | Status: COMPLETED